• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy.

作者信息

Esmail Hanif, Wilkinson Robert J

机构信息

1 Wellcome Center for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa.

2 Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.

出版信息

Ann Am Thorac Soc. 2017 May;14(5):621-623. doi: 10.1513/AnnalsATS.201701-055ED.

DOI:10.1513/AnnalsATS.201701-055ED
PMID:28459619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5427745/
Abstract
摘要

相似文献

1
Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy.降低接受抗TNF治疗患者的结核病风险
Ann Am Thorac Soc. 2017 May;14(5):621-623. doi: 10.1513/AnnalsATS.201701-055ED.
2
Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.接受抗TNF治疗患者的潜伏性结核感染检测及活动性结核预防：一项意大利全国性调查。
Int J Rheum Dis. 2016 Aug;19(8):799-805. doi: 10.1111/1756-185X.12708. Epub 2015 Jul 14.
3
Myxoedema coma following commencement of anti-TNF therapy and tuberculosis prophylaxis in a patient with RA and latent tuberculosis infection.
Postgrad Med J. 2019 May;95(1123):281. doi: 10.1136/postgradmedj-2019-136458. Epub 2019 May 13.
4
Active tuberculosis risk with tumor necrosis factor inhibitors after treating latent tuberculosis.治疗潜伏性结核后使用肿瘤坏死因子抑制剂的结核发病风险。
J Clin Rheumatol. 2014 Mar;20(2):68-73. doi: 10.1097/RHU.0000000000000074.
5
Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence.肿瘤坏死因子-α抑制剂治疗下结核病风险的预测特征：来自高背景患病率的大型多中心队列的报告
J Rheumatol. 2016 Mar;43(3):524-9. doi: 10.3899/jrheum.150177. Epub 2016 Jan 15.
6
Tuberculosis and anti-TNF treatment: experience of a central London hospital.结核与抗 TNF 治疗：伦敦某中心医院的经验。
Clin Rheumatol. 2011 Mar;30(3):399-401. doi: 10.1007/s10067-010-1605-1. Epub 2010 Oct 23.
7
Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study.类风湿关节炎患者接受靶向治疗后发生结核病的风险：一项前瞻性单中心队列研究。
J Korean Med Sci. 2021 Mar 15;36(10):e70. doi: 10.3346/jkms.2021.36.e70.
8
Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis.结核高发地区抗 TNF-α 治疗前 INH 化学预防的中远期随访结果。
Wien Klin Wochenschr. 2013 Oct;125(19-20):616-20. doi: 10.1007/s00508-013-0417-0. Epub 2013 Sep 6.
9
Follow-up testing of interferon-gamma release assays are useful in ankylosing spondylitis patients receiving anti-tumor necrosis factor alpha for latent tuberculosis infection.对于接受抗肿瘤坏死因子α治疗的强直性脊柱炎患者，若怀疑存在潜伏性结核感染，γ-干扰素释放试验的随访检测很有用。
J Korean Med Sci. 2014 Aug;29(8):1090-3. doi: 10.3346/jkms.2014.29.8.1090. Epub 2014 Jul 30.
10
Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.QuantiFERON-TB Gold 检测和结核菌素皮肤试验在肿瘤坏死因子-α拮抗剂治疗患者中用于潜伏性结核感染的检测。
Clin Exp Rheumatol. 2013 Jan-Feb;31(1):111-7. Epub 2012 Oct 24.

引用本文的文献

1
Diagnostic dilemma of a new endobronchial lesion in a patient on anti-tuberculosis regimen: unveiling tuberculosis immune reconstitution inflammatory syndrome.一名正在接受抗结核治疗的患者出现新的支气管内病变的诊断困境：揭示结核免疫重建炎症综合征。
BMC Infect Dis. 2025 May 2;25(1):648. doi: 10.1186/s12879-025-11047-6.
2
Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review.用于炎症性指甲疾病的生物制剂和小分子药物：一篇叙述性综述。
Indian Dermatol Online J. 2024 Dec 26;16(1):50-58. doi: 10.4103/idoj.idoj_445_24. eCollection 2025 Jan-Feb.
3
Disseminated, fatal reactivation of bovine tuberculosis in a patient treated with adalimumab: a case report and review of the literature.一例接受阿达木单抗治疗的患者发生播散性、致命性牛型结核再激活：病例报告及文献复习
Infection. 2025 Feb;53(1):481-487. doi: 10.1007/s15010-024-02364-0. Epub 2024 Aug 14.
4
Corticosteroid-induced exacerbation of cryptic miliary tuberculosis to acute respiratory distress syndrome: A case report.皮质类固醇诱发隐匿性粟粒型肺结核恶化为急性呼吸窘迫综合征：一例报告
Medicine (Baltimore). 2020 Nov 13;99(46):e23204. doi: 10.1097/MD.0000000000023204.

本文引用的文献

1
Efficacy of Treatment for Latent Tuberculosis in Patients Undergoing Treatment with a Tumor Necrosis Factor Antagonist.肿瘤坏死因子拮抗剂治疗患者潜伏性结核病的疗效。
Ann Am Thorac Soc. 2017 May;14(5):690-697. doi: 10.1513/AnnalsATS.201608-647OC.
2
From latent to patent: rethinking prediction of tuberculosis.从潜伏到显性：重新思考结核病的预测
Lancet Respir Med. 2017 Apr;5(4):243-244. doi: 10.1016/S2213-2600(16)30419-2. Epub 2016 Dec 22.
3
Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.在接受肿瘤坏死因子α拮抗剂治疗的全国性炎症性肠病患者队列中进行的结核病筛查与再激活情况
Inflamm Bowel Dis. 2017 Feb;23(2):254-260. doi: 10.1097/MIB.0000000000001003.
4
QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response.结核菌素接种后QuantiFERON检测结果转换在HIV感染中很常见，且与基线反应有关。
BMC Infect Dis. 2016 Oct 7;16(1):545. doi: 10.1186/s12879-016-1875-6.
5
Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.阴性筛查不能排除接受抗TNF治疗的炎症性肠病患者患结核病的风险：GETAID队列的描述性研究。
J Crohns Colitis. 2016 Oct;10(10):1179-85. doi: 10.1093/ecco-jcc/jjw129. Epub 2016 Jul 11.
6
Diagnosis and treatment of latent tuberculosis infection.潜伏性结核感染的诊断与治疗
Tuberc Respir Dis (Seoul). 2015 Apr;78(2):56-63. doi: 10.4046/trd.2015.78.2.56. Epub 2015 Apr 2.
7
Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.使用抗TNF药物的韩国炎症性肠病患者活动性结核感染的重大风险及相关因素。
World J Gastroenterol. 2015 Mar 21;21(11):3308-16. doi: 10.3748/wjg.v21.i11.3308.
8
The ongoing challenge of latent tuberculosis.潜伏性结核的持续挑战。
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130437. doi: 10.1098/rstb.2013.0437. Print 2014.
9
Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy.评估用于识别在开始 TNF-α 拮抗剂治疗前需要进行结核化学预防的慢性风湿性疾病患者的筛选方法。
Thorax. 2013 Oct;68(10):955-61. doi: 10.1136/thoraxjnl-2013-203436. Epub 2013 Aug 23.
10
Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.在一组开始接受抗肿瘤坏死因子治疗的风湿性疾病患者中，比较两种γ干扰素释放试验与结核菌素皮肤试验用于结核病筛查的效果。
Clin Vaccine Immunol. 2011 Dec;18(12):2102-8. doi: 10.1128/CVI.05299-11. Epub 2011 Oct 12.